Biodesix updates up to $50M at-the-market offering; up to $28.2M remains after $21.8M in prior sales

Filed August 7, 2024 · ~1 min read

Key Changes

• high

  The ATM program has a maximum aggregate offering price of up to $50 million, of which approximately up to $28.2 million remains available.

  The Offering view on EDGAR →
• high

  The company has already sold 6,403,703 shares under the Sales Agreement for gross proceeds of $21,772,134.37.

  The Offering view on EDGAR →
• medium

  Public float is $116.1 million, based on 73,967,025 shares held by non-affiliates at $1.57 per share.

  The Offering view on EDGAR →